Artemisinin API is a potent antimalarial agent derived from Artemisia annua, used in the treatment of Plasmodium falciparum malaria, particularly as part of artemisinin-based combination therapies (ACTs). It works by producing free radicals within the parasite, leading to rapid parasite clearance. Artemisinin API is manufactured under GMP-compliant conditions and is suitable for oral and injectable antimalarial formulations.

Artemisinin API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.